Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass
Clinical trial NCT00048308 · COMPLETED
Trial details
- NCT number
- NCT00048308
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2003-03-01
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.